Patient safety, research, and evidence: getting to improved systems.

J Gen Intern Med

Center for Quality Improvement and Patient Safety, U.S. Agency for Healthcare Research and Quality, Department of Health and Human Services, Rockville, MD, USA.

Published: July 2004

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1492490PMC
http://dx.doi.org/10.1111/j.1525-1497.2004.40405.xDOI Listing

Publication Analysis

Top Keywords

patient safety
4
safety evidence
4
evidence improved
4
improved systems
4
patient
1
evidence
1
improved
1
systems
1

Similar Publications

Medical Malpractice Litigation Associated With Anesthesia: Result From the Lexis China Claims Database 2013 to 2022.

J Perianesth Nurs

January 2025

Department of Anesthesiology, West China Second Hospital, Sichuan University, Key Laboratory of Birth Deficits and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Renmin Nanlu, Chengdu, China. Electronic address:

Purpose: This study conducted an analysis of medical malpractice litigation associated with anesthesia from 2013 to 2022, aiming to evaluate incidents of anesthesia-related safety concerns among surgical patients. The use of data derived from medical malpractice claims provided valuable insights into potential risks associated with anesthesia, contributing to the mitigation of medical malpractice and the enhancement of patient safety.

Design: A retrospective study.

View Article and Find Full Text PDF

Introduction: Children and adolescents with neurodevelopmental and psychiatric comorbidities, particularly autism spectrum disorder and developmental delays (ASD/DD), present unique challenges in pediatric emergency department (PED) settings. Youths with ASD/DD are prone to sensory overload and frequently exhibit agitation and/or aggression, necessitating specialized interventions. However, PEDs lack standardized protocols for managing behavioral dysregulation in this vulnerable population, often relying on anecdotal treatment approaches that hinder the provision of safe, effective and individualized care.

View Article and Find Full Text PDF

Case of Fatal Hepatitis Related to HEV-3 Infection in Central Italy.

Viruses

November 2024

Microbiology and Clinical Microbiology Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.

Hepatitis E virus (HEV) is a global health problem, causing an estimated 20 million infections annually. Thus, the management of HEV requires special consideration. In developed countries, hepatitis E is mainly recognized as a foodborne disease (mainly transmitted via undercooked meat consumption) that is generally caused by genotype 3 and 4 circulating in various animals, including pigs and wild boars.

View Article and Find Full Text PDF

Design and Evaluation of Augmented Reality-Enhanced Robotic System for Epidural Interventions.

Sensors (Basel)

December 2024

Surgical Performance Enhancement and Robotics (SuPER) Centre, Department of Surgery, McGill University, Montreal, QC H3A 0G4, Canada.

The epidural injection is a medical intervention to inject therapeutics directly into the vicinity of the spinal cord for pain management. Because of its proximity to the spinal cord, imprecise insertion of the needle may result in irreversible damage to the nerves or spinal cord. This study explores enhancing procedural accuracy by integrating a telerobotic system and augmented reality (AR) assistance.

View Article and Find Full Text PDF

How to Fabricate Hyaluronic Acid for Ocular Drug Delivery.

Pharmaceutics

December 2024

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.

This review aims to examine existing research on the development of ocular drug delivery devices utilizing hyaluronic acid (HA). Renowned for its exceptional biocompatibility, viscoelastic properties, and ability to enhance drug bioavailability, HA is a naturally occurring biopolymer. The review discussed specific mechanisms by which HA enhances drug delivery, including prolonging drug residence time on ocular surfaces, facilitating controlled drug release, and improving drug penetration through ocular tissues.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!